Dow Jones 30 Stocks SEC Filings — July 21, 2026

Raised full-year adjusted EPS guidance to $8.80-$8.95 from $8.50-$8.70, a 3.5% increase at the midpoint, implying confidence in H2 2026 operational momentum

Adjusted operating margin improved 40 bps YoY to 24.9%, while GAAP margin fell 290 bps—the divergence suggests underlying business strength masked by one-time charges

Safety & Industrial segment grew 8% YoY and Transportation & Electronics grew 6%, offsetting Consumer segment decline of 1.8%, showing a shift toward higher-growth industrial end markets

Issued $10B in fixed/floating rate notes with coupons from 5.240% to 6.215%, locking in long-term funding at attractive rates relative to potential future rate cuts

The 30-year tranche ($3.0B at 6.215%) is the highest coupon, indicating the firm is willing to pay up for duration—a bet that rates have peaked

EVP Vanessa Broadhurst sold 23,054 shares at $251.27 for ~$5.79M, reducing her holdings to 23,003 shares—a near-complete liquidation of her position after exercising options

GAAP operating income fell 13.7% YoY to $984M, and GAAP operating margin dropped 290 bps to 15.1%, the lowest in recent quarters, driven by $336M in divestiture losses and $183M in litigation costs

Consumer segment sales declined 1.8% YoY, with Home Improvement down 3.2% and Packaging & Expression down 10.3%, signaling weakness in discretionary consumer categories

Cash and cash equivalents fell 43.6% from $5.235B to $2.955B in H1 2026, largely due to $2.993B in treasury stock purchases—aggressive buybacks reducing financial flexibility [NEUTRAL/BEARISH]

H1 2026 net income attributable to 3M fell 14% to $1.586B from $1.839B in H1 2025, despite Q2 improvement, indicating a weak first quarter

GAAP operating margin fell 290 bps YoY to 15.1%, while adjusted margin rose 40 bps—a 980 bps gap between GAAP and adjusted margins, the widest in recent history, raising questions about the sustainability of adjusted earnings

$183M in net costs for significant litigation and PFAS exit in Q2 alone, with no end in sight—these costs could persist for years and may escalate

Cash balance dropped 43.6% in six months to $2.955B, driven by $2.993B in buybacks—if operating cash flow weakens, the company could face liquidity pressure

Consumer segment sales declined 1.8% YoY, with Packaging & Expression down 10.3%—this is a structural decline, not just cyclical, as consumers shift spending

EVP Broadhurst sold 23,054 shares at $251.27, representing ~100% of her post-exercise holdings—a senior executive's complete exit is a strong negative signal

The sale occurred at $251.27, near the stock's 52-week range—the executive chose to sell near the top rather than hold, suggesting a lack of confidence in near-term upside

$10B in new debt issuance across three tranches increases total leverage—if credit markets tighten or the firm's trading revenue declines, debt service could strain earnings

$336M loss on business divestitures in Q2 indicates the company is selling assets at a discount, potentially destroying shareholder value

$100M in transformation costs in Q2, with no completion date—restructuring programs often run over budget and take longer than expected

Trading at ~17x forward adjusted EPS ($8.80-$8.95) with 11% adjusted EPS growth, 5.4% organic sales growth, and a raised guidance—if adjusted earnings are sustainable, the stock is undervalued relative to industrial peers

Safety & Industrial (+8% YoY) and Transportation & Electronics (+6% YoY) are outperforming, suggesting the company is gaining share in cyclical industrial markets

H1 2026 operating cash flow improved to $1.56B from -$1.033B in H1 2025, a $2.6B swing—if this trend continues, the company can fund buybacks and dividends without further cash burn

The $10B issuance at 5.240%-6.215% locks in long-term funding ahead of potential rate cuts—if the Fed cuts rates in H2 2026, these notes become cheap capital

The ability to issue $10B in unsecured notes across 3 tranches (including 30-year) demonstrates strong market access and investor confidence in credit quality

The EVP's sale may be for personal diversification, not a signal of company weakness—J&J's diversified healthcare model and 60+ year dividend growth streak remain intact

Adjusted operating margin improved 40 bps YoY to 24.9%, and with transformation costs expected to decline, margins could expand further in H2 2026

5.4% organic sales growth in Q2, above GDP growth, suggests the company is gaining market share in core industrial markets

3M spent $2.99B on buybacks (draining cash 44%), while Goldman issued $10B in new debt—two Dow components taking opposite approaches to capital structure, reflecting different growth strategies and risk appetites [IMPLICATION: Investors should favor companies with sustainable capital return policies]

3M's GAAP operating margin fell 290 bps while adjusted margin rose 40 bps—a 330 bps divergence that highlights the growing use of non-GAAP metrics to mask underlying costs [IMPLICATION: Scrutinize adjusted earnings quality; prefer companies with narrow GAAP-adjusted gaps]

J&J's EVP sold near the stock's 52-week high, a pattern often seen before sector corrections—if other Dow healthcare insiders follow, it could signal a peak in healthcare valuations [IMPLICATION: Monitor insider activity across Dow healthcare components for broader selling patterns]

Goldman's $10B issuance across 3 tranches (5-30 year maturities) shows deep demand for investment-grade corporate debt, suggesting credit markets remain open and pricing is attractive for blue-chip issuers [IMPLICATION: Other Dow financials may follow with opportunistic debt issuance]

3M's Consumer segment declined 1.8% YoY while industrial segments grew 6-8%—this bifurcation suggests consumer-facing divisions of industrial conglomerates are underperforming, a trend that may spread to other Dow industrials with consumer exposure [IMPLICATION: Avoid Dow stocks with high consumer discretionary exposure]

Scheduled to discuss Q2 results—watch for details on litigation reserves, PFAS exit costs, and whether the $336M divestiture loss is a one-time event or a trend [Date: Late July 2026]

Cash fell 43.6% to $2.955B—if the next filing shows further decline below $2.5B, it could signal a liquidity crunch or need for debt issuance [Monitor: 10-Q for Q3 2026]

After EVP Broadhurst's $5.79M sale, watch for other C-suite filings—if multiple executives sell, it would confirm a bearish signal [Monitor: SEC Form 4 filings over next 30 days]

The $10B raised needs to be deployed—watch for M&A announcements, dividend increases, or buyback authorizations in the next 1-2 quarters [Monitor: 8-K filings and earnings calls]

Packaging & Expression down 10.3% and Home Improvement down 3.2%—if this accelerates in Q3, it could signal a broader consumer recession [Monitor: Q3 2026 results in October]

The 980 bps gap between GAAP and adjusted margins needs to narrow—if special items persist, the stock could re-rate lower [Monitor: Q3 2026 10-Q]

The 6.215% coupon on the 30-year tranche is high—if rates fall, Goldman could refinance at lower rates, but if rates rise, the debt becomes expensive [Monitor: Fed meetings and yield curve movements]

$100M in Q2 with no end date—watch for updated guidance on restructuring completion and expected savings [Monitor: Earnings call transcripts]